Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
55.2M
-
Shares change
-
+372K
-
Total reported value, excl. options
-
$947M
-
Value change
-
+$5.22M
-
Put/Call ratio
-
1.45
-
Number of buys
-
72
-
Number of sells
-
-87
-
Price
-
$17.14
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2021
200 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.2M shares
of 58.9M outstanding shares and own 93.79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.7M shares), VANGUARD GROUP INC (3.99M shares), Palo Alto Investors LP (3.79M shares), STATE STREET CORP (3.4M shares), RENAISSANCE TECHNOLOGIES LLC (3.28M shares), MACQUARIE GROUP LTD (3.24M shares), LSV ASSET MANAGEMENT (2.13M shares), Epoch Investment Partners, Inc. (1.98M shares), ARMISTICE CAPITAL, LLC (1.97M shares), and DIMENSIONAL FUND ADVISORS LP (1.93M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.